Widad inks agreement with Rinani


KUALA LUMPUR: Widad Group Bhd has signed a memorandum of collaboration with Rinani Dynamic Sdn Bhd for the distribution, marketing and selling of the Covid-19 vaccine.

In a statement Tuesday, Widad said Rinani is the local representative in Malaysia for VAXART Inc, an US-based entity that is listed on Nasdaq with respect to its ongoing development of an oral-based (tablet) Covid-19 vaccine.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Widad , Rinani , Vaxart , Covid-19

   

Next In Business News

Etiquette at an open house
Trump’s presidency a boon
Elevating outdoor oases
GDA stands firm on RM11 offer for MAHB despite directors' rejection
Ringgit expected to trade within narrow range next week amid holiday calm
Oil steady as markets weigh Fed rate-cut expectations
The beauty of Hygr’s formula
Top Glove bullish on outlook amid steady order inflows
US market - prudence is golden
Book speaks volumes about Penang food

Others Also Read